MDT Medtronic Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 70
Relative Strength: Rel. Strength: 25
Relative Valuation: Rel. Valuation: 56
Relative Profitability: Rel. Profitability: 71

EPS in 2026 (TTM): $3.75

Last Report Period Date: Apr 24, 2026

As of June 2026, MDT's current EPS stands at $3.75, according to the latest financial reports. For the year 2026, the company recorded an earnings per share (EPS) of $3.75, which marks an increase compared to its EPS of $3.63 in 2025. MDT reported an EPS of $0.98 for the quarterly report ending on Apr 24, 2026.

MDT earnings history

Historical annual and quarterly earnings per share (EPS) data for Medtronic
EPS (TTM)
$3.75
EPS Growth YoY (Quarterly)
18.1%
EPS (Quarterly)
$0.98
EPS Growth (Quarterly)
10.1%

For 2026, Medtronic's EPS was $3.75, an increase of 3.3% from $3.63 in 2025. For the fiscal quarter that ended on Apr 24, 2026, the per-share earnings was $0.98, showing a 18.1% increase from the same quarter last year. For the twelve months ending April 2026, the EPS is $3.75. For the year 2025, the yearly earnings per share was $3.63, marking an increase of 31% from 2024.

MDT earnings chart

MDT EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
18.1%
EPS growth YoY
3.3%
EPS growth 3Y avg
9.8%
EPS growth 5Y avg
6.9%

Medtronic has registered an increase in EPS of 18.1% during the last 12 months (YoY, quarterly). In the last three years, MDT recorded an average annual EPS growth rate of 9.8%. Medtronic had an average annual EPS growth rate of 6.9% during the last 5 years. Across the last decade, MDT had an average annual EPS growth of 4.1%.

MDT Earnings Waterfall

Breakdown of revenue, profit and net income for Medtronic

MDT Earnings vs Peers

What are the earnings of MDT compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
BSX Boston Scientific Corp 18.65 55.6% 63.3% N/A
CNMD CONMED Corp 18.84 -64.6% N/A 35.7%
MDT Medtronic plc 21.4 3.3% 9.8% 6.9%
ABT Abbott Laboratories 25.11 -51.4% -1.8% 8.2%
JNJ Johnson & Johnson 26.95 90.6% 17.7% 14.8%
SYK Stryker Corp 35.31 8% 10.9% 14.8%
EW Edwards Lifesciences Corp 45.63 -73.6% -9.2% 6.9%
BAX Baxter International Inc N/A -47.2% N/A N/A
ACH Accendra Health Inc. N/A -202.5% N/A N/A
IART Integra Lifesciences Holdings Corp N/A -7,388.9% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.